Inoviq Ltd has released a press release.
Positive results for SubB2M Breast Cancer Test
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Inoviq
- Appendix 4C & Quarterly Activities Report - December 2022
- Positive EXO-NET Results in Ovarian Cancer
- MST Access Diagnostics Forum Presentation
- CEO AGM Presentation
- INOVIQ Settles Legal Proceedings
Later from Inoviq
- Appendix 4D and Half Year Financial Report
- Appendix 4C and Quarterly Activities Report - March 2023
- ISEV Meeting Presentations
- Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
- SubB2M/CA15.3 Clinical Validation Data Investor Presentation
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq